2026-2034 年神經內科栓塞器材全球市場規模、佔有率、趨勢和成長分析報告。

全球神經系統栓塞器材市場預計將從2025年的18.4億美元成長至2034年的32.4億美元，2026年至2034年的複合年成長率（CAGR）為6.48%。該市場正經歷顯著成長，主要原因是腦動脈瘤、動靜脈畸形和中風相關疾病等神經系統疾病的發生率不斷上升。栓塞器械廣泛應用於微創神經血管治療，以阻斷異常血流並預防危及生命的併發症。人們對先進治療方法的認知不斷提高以及醫療基礎設施的改善，正在推動已開發國家和新興市場市場的擴張。

關鍵成長要素包括對微創介入治療需求的不斷成長、神經血管成像技術的進步以及專業栓塞產品的日益普及。醫療專業人員正在利用創新彈簧圈、液體栓塞劑和血流導向裝置來改善治療效果並降低手術相關風險。神經專科中心的普及和神經血管研究投入的增加進一步推動了市場發展。

科技創新不斷提升手術精準度和病患復原效果，​​使未來前景極為光明。新型栓塞材料、機器人輔助介入治療和先進的影像導引系統有望創造新的成長機會。醫療成本的不斷上漲以及易患神經系統疾病的老年人口的增加，將進一步推動市場需求。隨著微創治療的普及，市場預計將持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球神經內科栓塞器材市場：依產品分類

• 市場分析、洞察與預測
• 栓塞線圈
• 液體栓塞系統
• 血流導向支架
• 動脈瘤夾
• 其他產品

第5章：全球神經內科栓塞器材市場：依治療類型分類

• 市場分析、洞察與預測
• 缺血性中風解決方案
• 出血性中風解決方案

第6章：全球神經內科栓塞器材市場：依適應症分類

• 市場分析、洞察與預測
• 腦動脈瘤
• 動靜脈畸形
• 其他改編

第7章 全球神經內科栓塞器材市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他最終用戶

第8章 全球神經內科栓塞器材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Johnson & Johnson
  • Abbott Laboratories
  • Medtronic Plc
  • Heraeus Holding
  • Stryker Corporation
  • Boston Scientific Corporation
  • Kaneka Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Merit Medical Systems Inc
  • Penumbra Inc
  • Asahi Intecc Co. Ltd
  • MicroVention Inc

The global embolization devices for neurology market size is expected to reach USD 3.24 Billion in 2034 from USD 1.84 Billion in 2025, growing at a CAGR of 6.48 during 2026-2034.This market is experiencing significant growth due to the increasing prevalence of neurological disorders such as cerebral aneurysms, arteriovenous malformations, and stroke-related conditions. Embolization devices are widely used in minimally invasive neurovascular procedures to block abnormal blood flow and prevent life-threatening complications. Growing awareness of advanced treatment options and improvements in healthcare infrastructure are contributing to market expansion across developed and emerging regions.

Key growth drivers include rising demand for minimally invasive interventions, advancements in neurovascular imaging technologies, and increasing adoption of specialized embolization products. Healthcare providers are utilizing innovative coils, liquid embolic agents, and flow diversion devices to improve treatment outcomes and reduce procedural risks. Expanding access to specialized neurological care centers and increasing investments in neurovascular research are further supporting market development.

The future outlook remains highly promising as technological innovations continue improving procedural precision and patient recovery outcomes. Emerging embolization materials, robotic-assisted interventions, and enhanced imaging guidance systems are expected to create new growth opportunities. Increasing healthcare spending and a growing aging population susceptible to neurological disorders will further drive demand. As minimally invasive treatments become the preferred approach, the market is expected to witness sustained growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Embolization Coils
• Liquid Embolic Systems
• Flow Diversion Stents
• Aneurysm Clips
• Other Products

By Treatment

• Ischemic Stroke Solution
• Hemorrhagic Stroke Solutions

By Indication

• Brain Aneurysms
• Arteriovenous Malformation
• Other Indications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B. Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Embolization Coils Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Liquid Embolic Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Flow Diversion Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Aneurysm Clips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Ischemic Stroke Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemorrhagic Stroke Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Brain Aneurysms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Arteriovenous Malformation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Treatment
  • 8.2.3 By Indication
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Treatment
  • 8.3.3 By Indication
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Treatment
  • 8.4.3 By Indication
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Treatment
  • 8.5.3 By Indication
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Treatment
  • 8.6.3 By Indication
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Medtronic Plc
  • 10.2.4 Heraeus Holding
  • 10.2.5 Stryker Corporation
  • 10.2.6 Boston Scientific Corporation
  • 10.2.7 Kaneka Corporation
  • 10.2.8 Terumo Corporation
  • 10.2.9 B. Braun Melsungen AG
  • 10.2.10 Cook Medical LLC
  • 10.2.11 Integer Holdings Corporation
  • 10.2.12 Merit Medical Systems Inc
  • 10.2.13 Penumbra Inc
  • 10.2.14 Asahi Intecc Co. Ltd
  • 10.2.15 MicroVention Inc